Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Common Equity: 2023-2024

Historic Common Equity for Upstream Bio (UPB) over the last 2 years, with Dec 2024 value amounting to $469.9 million.

  • Upstream Bio's Common Equity rose 336.16% to $378.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $378.6 million, marking a year-over-year increase of 336.16%. This contributed to the annual value of $469.9 million for FY2024, which is 481.60% up from last year.
  • As of FY2024, Upstream Bio's Common Equity stood at $469.9 million, which was up 481.60% from -$123.1 million recorded in FY2023.
  • In the past 5 years, Upstream Bio's Common Equity ranged from a high of $469.9 million in FY2024 and a low of -$123.1 million during FY2023.
  • Over the past 2 years, Upstream Bio's median Common Equity value was $173.4 million (recorded in 2023), while the average stood at $173.4 million.
  • Data for Upstream Bio's Common Equity shows a peak YoY skyrocketed of 481.60% (in 2024) over the last 5 years.
  • Over the past 2 years, Upstream Bio's Common Equity (Yearly) stood at -$123.1 million in 2023, then skyrocketed by 481.60% to $469.9 million in 2024.